Enzyme vs NEAR Protocol — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while NEAR Protocol trades at Rp37,337 (market cap Rp48,35T, Rp3,58T 24h volume). The key difference: NEAR Protocol is far larger — about 360471.2× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 1,3B NEAR for NEAR Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and NEAR Protocol for 50 Days on average.
| MLN | NEAR | |
|---|---|---|
Market Cap | Rp134,13M | Rp48,35T |
Volume (24h) | Rp104,56M | Rp3,58T |
Circulating Supply | 3,3M MLN | 1,3B NEAR |
Typical Hold Time | 28 Days | 50 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
NEAR Protocol is trading at Rp37,313 with a market cap of Rp48.86T, showing bullish technical signals from moving averages despite a neutral oscillator stance. The asset is positioned above its pivot point of Rp37,135, with immediate resistance at Rp38,321. Recent news highlights its appeal in a lower interest rate environment as a crypto alternative. Hold time averages 50 days, indicating moderate investor retention.
Overall outlook is cautiously optimistic due to technical strength and macroeconomic tailwinds, but risks include high RSI levels suggesting overbought conditions and crypto market volatility. Key opportunities lie in network growth, while regulatory uncertainties and liquidity fluctuations pose significant threats.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →NEAR is a sharded, developer-friendly, proof-of-stake public blockchain, built by a world-class team that has built some of the world's only sharded databases at scale. The network runs on a Proof-of-Stake (PoS) convention mechanism called Nightshade, which aims to offer scalability and stable costs. nn
Read more on NEAR →